Kimura Kazumi, Iguchi Yasuyuki, Shibazaki Kensaku, Kobayashi Kazuto, Uemura Junichi, Aoki Junya, Yamashita Shinji, Terasawa Yuka, Matsumoto Noriko
Department of Stroke Medicine, Kawasaki Medical School, Japan.
J Neurol Sci. 2008 Jul 15;270(1-2):48-52. doi: 10.1016/j.jns.2008.01.013. Epub 2008 Mar 4.
Intravenous administration of tissue plasminogen activator (t-PA) can improve clinical outcomes in patients with acute ischemic stroke. The most important complication of t-PA therapy is intracerebral hemorrhage (ICH). The aim of this study was to use serial MRI studies to identify independent predictors of symptomatic and asymptomatic ICH after t-PA therapy.
Consecutive anterior-circulation ischemic stroke patients treated with t-PA within 3 h of stroke onset were studied prospectively. To identify the presence of recanalization in the occluded arteries and the presence of ICH, MRI, including diffusion weighted imaging (DWI), T2*, and magnetic resonance angiography (MRA), was performed before and 1 h, 24 h, and 5-7 days after t-PA thrombolysis. The independent predictors of ICH were determined using multivariate logistic regression analysis.
41 patients (21 males, 20 females; mean age, 73.2+/-10.7 years) were enrolled, and 19 ICHs (1 symptomatic, 18 asymptomatic) were observed on T2*. The initial MRA demonstrated occluded brain arteries in 31 patients (75.6%), of which follow-up MRA at 1 h, 24 h, and 5-7 days after t-PA therapy revealed recanalization in 48.4%, 80.0%, and 90.0% of patients, respectively. The frequency of recanalization within 1 h after t-PA therapy did not differ between ICH and No-ICH groups, but the ICH group had more frequent recanalization between 1 h and 24 h after t-PA than the No-ICH group (50.0% vs. 4.5%, P=0.001). The ICH group had arterial fibrillation (AF) more frequently than the No-ICH group (78.9% vs. 27.3%, P=0.001). Compared to the No-ICH group, the NIHSS score was higher (16.4+/-5.7 vs. 11.5+/-6.5, P=0.011) and the ASPECTS-DWI value (a normal DWI has an ASPECTS-DWI value of 11 points) was lower (7.3+/-2.4 vs. 8.9+/-1.9, P=0.019) in the ICH group. Multivariate logistic regression analysis demonstrated that the presence of recanalization between 1 and 24 h after the end of t-PA infusion (OR: 20.2; CI: 1.0-340.9; P=0.037) was the only independent predictor of ICH.
Recanalization of occluded arteries between 1 and 24 h but not within 1 h after t-PA infusion should be independently associated with symptomatic and asymptomatic ICH after t-PA therapy.
静脉注射组织型纤溶酶原激活剂(t-PA)可改善急性缺血性脑卒中患者的临床预后。t-PA治疗最重要的并发症是脑出血(ICH)。本研究的目的是通过系列MRI研究确定t-PA治疗后有症状和无症状ICH的独立预测因素。
对卒中发作3小时内接受t-PA治疗的连续性前循环缺血性脑卒中患者进行前瞻性研究。为确定闭塞动脉再通情况及ICH的存在,在t-PA溶栓前、溶栓后1小时、24小时和5 - 7天进行MRI检查,包括弥散加权成像(DWI)、T2*加权成像和磁共振血管造影(MRA)。使用多因素逻辑回归分析确定ICH的独立预测因素。
共纳入41例患者(男性21例,女性20例;平均年龄73.2±10.7岁),T2*加权成像观察到19例ICH(1例有症状,18例无症状)。初始MRA显示31例患者(75.6%)脑动脉闭塞,其中t-PA治疗后1小时、24小时和5 - 7天的随访MRA显示再通率分别为48.4%、80.0%和90.0%。t-PA治疗后1小时内ICH组和无ICH组的再通频率无差异,但t-PA治疗后1至24小时内ICH组的再通频率高于无ICH组(50.0% vs. 4.5%,P = 0.001)。ICH组房颤(AF)发生率高于无ICH组(78.9% vs. 27.3%,P = 0.001)。与无ICH组相比,ICH组美国国立卫生研究院卒中量表(NIHSS)评分更高(16.4±5.7 vs. 11.5±6.5,P = 0.011),DWI的脑缺血半暗带评分(ASPECTS-DWI)值更低(正常DWI的ASPECTS-DWI值为11分,7.3±2.4 vs. 8.9±1.9,P = 0.019)。多因素逻辑回归分析表明,t-PA输注结束后1至24小时内出现再通(比值比:20.2;95%置信区间:1.0 - 340.9;P = 0.037)是ICH的唯一独立预测因素。
t-PA输注后1至24小时而非1小时内闭塞动脉的再通与t-PA治疗后有症状和无症状ICH独立相关。